DrugPatentWatch Database Preview
Esketamine hydrochloride - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for esketamine hydrochloride and what is the scope of patent protection?
Esketamine hydrochloride
is the generic ingredient in one branded drug marketed by Janssen Pharms and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Esketamine hydrochloride has seven patent family members in seven countries.
One supplier is listed for this compound.
Summary for esketamine hydrochloride
International Patents: | 7 |
US Patents: | 2 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Suppliers / Packagers: | 1 |
Bulk Api Vendors: | 19 |
Clinical Trials: | 61 |
Patent Applications: | 24 |
DailyMed Link: | esketamine hydrochloride at DailyMed |
Recent Clinical Trials for esketamine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospital, Basel, Switzerland | Phase 2 |
Yangzhou University | N/A |
Women's Hospital School Of Medicine Zhejiang University | Phase 4 |
US Patents and Regulatory Information for esketamine hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | SPRAVATO | esketamine hydrochloride | SPRAY;NASAL | 211243-001 | Mar 5, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Janssen Pharms | SPRAVATO | esketamine hydrochloride | SPRAY;NASAL | 211243-001 | Mar 5, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Janssen Pharms | SPRAVATO | esketamine hydrochloride | SPRAY;NASAL | 211243-001 | Mar 5, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for esketamine hydrochloride
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 20090029690 | Start Trial |
Israel | 194198 | Start Trial |
European Patent Office | 2012762 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |